Morgan Stanley »

Unicycive Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $4.8k 1.0k 4.77

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Morgan Stanley

Top funds holding Unicycive Therapeutics

Vivo Capital
Octagon Capital Advisors
Nantahala Capital Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Logos Global Management
Geode Capital Management
Squarepoint Ops
Longwood Capital Partners
State Street Corporation
Goldman Sachs Group
Citadel Advisors
XTX Topco
BlackRock
Northern Trust

View all funds holding Unicycive Therapeutics